Anbio Biotechnology Statistics
NASDAQ: NNNNHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
3.32-0.33 (-9.04%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Anbio Biotechnology by the numbers
Anbio Biotechnology has a market capitalization of $145.7 million based on 43.89M shares outstanding. Its trailing P/E ratio is 22.1. The stock trades 25.6% below its 50-day average and 78.7% below its 200-day average.
Average daily trading volume is 128.35K shares, or about $426,135 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NNNN valuation vs. peer median
| Metric | NNNN | Peer median | Difference |
|---|---|---|---|
| Market cap | $145.72M | $5.02M | +2803% |
| Avg. volume | 128.35K | 167.42K | -23% |
Peer median across 8 companies: ICCC, IMDX, VNRX, TRIB, BMRA, CDIO, QCLS, VRAX.
Valuation
- Market cap
- $145.72M
- P/E (TTM)
- 22.13
- Price / sales (latest FY)
- 16.85
- EPS (TTM)
- $0.15
- Shares outstanding
- 43.89M
Price and trading
- Previous close
- 3.65
- Open
- 3.65
- Day range
- 3.31 – 3.93
- 52-week range
- 3.09 – 44.73
- 52-week change
- -86.02%
- Beta
- —
- Volume
- 79.51K
- Average volume
- 128.35K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Apr 28, 2025
Additional statistics
- Market Cap
- 145.72M
- Pe
- 22.13
- Eps
- 0.15
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 44.73
- Week52 Low
- 3.09
- Avg Volume
- 128.35K
- Shares Outstanding
- 43.89M
- Ma50
- 4.47
- Ma200
- 15.61
- Earnings Date
- Apr 28, 2025
- Pct From52w High
- -92.58%
- Pct From52w Low
- 7.44%